Semaglutide and neurodevelopment: investigating risks arising from prenatal exposure to a widely popular drug for diabetes and obesity

2023/51/B/NZ7/02360

Keywords

Descriptors

  • NZ7_15: Toksykologia
  • NZ3_05: Neurobiologia molekularna
  • NZ7_14: Farmacja, farmakoterapia, farmakologia

Panel

NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution

Instytut Farmakologii PAN

Voivodeship: małopolskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

dr hab. Agnieszka Wnuk

Number of co-investigators in the project: 8

Call

OPUS 26 – announced on 2023-09-18

Amount awarded
2 996 320 PLN
Project start date
2024-10-01
Project end date
2028-09-30
Project duration
48 months (the same as in the proposal)
Project status
Pending project

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

« New search

Graphic design and implementation: Jakub Piotrowski